Literature DB >> 12379743

Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways.

Cheryl Twu1, Nancy Q Liu, Waldemar Popik, Michael Bukrinsky, James Sayre, Jaclyn Roberts, Shammas Rania, Vishnu Bramhandam, Kenneth P Roos, W Robb MacLellan, Milan Fiala.   

Abstract

We investigated 18 AIDS hearts (5 with and 13 without cardiomyopathy) by using immunocytochemistry and computerized image analysis regarding the roles of HIV-1 proteins and tumor necrosis factor ligands in HIV cardiomyopathy (HIVCM). HIVCM and cardiomyocyte apoptosis were significantly related to each other and to the expression by inflammatory cells of gp120 and tumor necrosis factor-alpha. In HIVCM heart, active caspase 9, a component of the mitochondrion-controlled apoptotic pathway, and the elements of the death receptor-mediated pathway, tumor necrosis factor-alpha and Fas ligand, were expressed strongly on macrophages and weakly on cardiomyocytes. HIVCM showed significantly greater macrophage infiltration and cardiomyocyte apoptosis rate compared with non-HIVCM. HIV-1 entered cultured neonatal rat ventricular myocytes by macropinocytosis but did not replicate. HIV-1- or gp120-induced apoptosis of rat myocytes through a mitochondrion-controlled pathway, which was inhibited by heparin, AOP-RANTES, or pertussis toxin, suggesting that cardiomyocyte apoptosis is induced by signaling through chemokine receptors. In conclusion, in patients with HIVCM, cardiomyocytes die through both mitochondrion- and death receptor-controlled apoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379743      PMCID: PMC137893          DOI: 10.1073/pnas.212327899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

1.  HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals.

Authors:  D Wolf; V Witte; B Laffert; K Blume; E Stromer; S Trapp; P d'Aloja; A Schürmann; A S Baur
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

2.  Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway.

Authors:  Nancy Q Liu; Albert S Lossinsky; Waldemar Popik; Xia Li; Chandrasekhar Gujuluva; Benjamin Kriederman; Jaclyn Roberts; Tatania Pushkarsky; Michael Bukrinsky; Marlys Witte; Martin Weinand; Milan Fiala
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

3.  Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells.

Authors:  Elizabeth A Sweeney; Hugues Lortat-Jacob; Gregory V Priestley; Betty Nakamoto; Thalia Papayannopoulou
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

4.  Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3.

Authors:  Yoshinori Seko; Nobuhiko Kayagaki; Ken-ichiro Seino; Hideo Yagita; Ko Okumura; Ryozo Nagai
Journal:  J Am Coll Cardiol       Date:  2002-04-17       Impact factor: 24.094

5.  Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage.

Authors:  Scott M Raidel; Chad Haase; Natalie R Jansen; Rodney B Russ; Roy L Sutliff; Leonard W Velsor; Brian J Day; Brian D Hoit; Allen M Samarel; William Lewis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-05       Impact factor: 4.733

6.  Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages.

Authors:  A C Saphire; M D Bobardt; Z Zhang; G David; P A Gallay
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Essential role of HIV type 1-infected and cyclooxygenase 2-activated macrophages and T cells in HIV type 1 myocarditis.

Authors:  Q N Liu; S Reddy; J W Sayre; V Pop; M C Graves; M Fiala
Journal:  AIDS Res Hum Retroviruses       Date:  2001-10-10       Impact factor: 2.205

Review 8.  AIDS cardiomyopathy: physiological, molecular, and biochemical studies in the transgenic mouse.

Authors:  W Lewis
Journal:  Ann N Y Acad Sci       Date:  2001-11       Impact factor: 5.691

Review 9.  Pathogenesis of HIV-associated cardiovascular complications.

Authors:  G Barbaro; S D Fisher; S E Lipshultz
Journal:  Lancet Infect Dis       Date:  2001-09       Impact factor: 25.071

10.  HIV type 1 glycoprotein 120 inhibits cardiac myocyte contraction.

Authors:  Fuhua Chen; Kevin Shannon; Shulan Ding; Monica E Silva; Glenn T Wetzel; Thomas S Klitzner; Paul Krogstad
Journal:  AIDS Res Hum Retroviruses       Date:  2002-07-20       Impact factor: 2.205

View more
  26 in total

Review 1.  Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development.

Authors:  Sheila M Keating; Evan S Jacobs; Philip J Norris
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

2.  Bacterial lipopolysaccharide enhances cardiac dysfunction but not retroviral replication in murine AIDS: roles of macrophage infiltration and toll-like receptor 4 expression.

Authors:  Alysia A Chaves; Reshma S Baliga; Michael J Mihm; Brandon L Schanbacher; Anupam Basuray; Cynthia Liu; Angela C Cook; Leona W Ayers; John Anthony Bauer
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

3.  NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy.

Authors:  Michael J Ross; Scott Martinka; Vivette D D'Agati; Leslie A Bruggeman
Journal:  J Am Soc Nephrol       Date:  2005-06-23       Impact factor: 10.121

Review 4.  Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries.

Authors:  Gerald S Bloomfield; Fawaz Alenezi; Felix A Barasa; Rebecca Lumsden; Bongani M Mayosi; Eric J Velazquez
Journal:  JACC Heart Fail       Date:  2015-08       Impact factor: 12.035

5.  Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.

Authors:  Antonella Bugatti; Chiara Urbinati; Cosetta Ravelli; Erik De Clercq; Sandra Liekens; Marco Rusnati
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

6.  A Novel Role of Proline Oxidase in HIV-1 Envelope Glycoprotein-induced Neuronal Autophagy.

Authors:  Jui Pandhare; Sabyasachi Dash; Bobby Jones; Fernando Villalta; Chandravanu Dash
Journal:  J Biol Chem       Date:  2015-09-01       Impact factor: 5.157

7.  Infection of cardiomyocytes and induction of left ventricle dysfunction by neurovirulent polytropic murine retrovirus.

Authors:  Mohammed Khaleduzzaman; Joseph Francis; Meryll E Corbin; Elizabeth McIlwain; Marc Boudreaux; Min Du; Tim W Morgan; Karin E Peterson
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

8.  Isothiocyanates ameliorate the symptom of heart dysfunction and mortality in a murine AIDS model by inhibiting apoptosis in the left ventricle.

Authors:  Jin-Nyoung Ho; Ho-Geun Yoon; Chang-Soo Park; Sunoh Kim; Woojin Jun; Ryowon Choue; Jeongmin Lee
Journal:  J Med Food       Date:  2012-09       Impact factor: 2.786

Review 9.  Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat.

Authors:  Ting Wang; Ru Yi; Linden Ann Green; Sarvesh Chelvanambi; Michael Seimetz; Matthias Clauss
Journal:  Cardiovasc Pathol       Date:  2015-07-09       Impact factor: 2.185

10.  Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease.

Authors:  Eliseo A Eugenin; Susan Morgello; Mary E Klotman; Arevik Mosoian; Patrick A Lento; Joan W Berman; Alison D Schecter
Journal:  Am J Pathol       Date:  2008-02-29       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.